LifeStance Health Group, Inc. (LFST) Tops Q3 EPS by 1c ; Offers Guidance

LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q3 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $363.81 million versus the consensus estimate of $355.54 million.

GUIDANCE:

LifeStance Health Group, Inc. sees Q4 2025 revenue of $368-388 million, versus the consensus of $380.8 million.

LifeStance Health Group, Inc. sees FY2025 revenue of $1.41-1.43 billion, versus the consensus of $1.41 billion.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• OSR Holdings renames itself OSR Health, keeps OSRH ticker
• Stifel Reiterates Hold Rating on BioMarin Pharmaceutical Inc. (BMRN)